OLD Category: immuno-oncology
December 28, 2018 / N Engl J Med.
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
December 12, 2018 / JCI Insight
Tumor-specific MHC-II expression drives a unique pattern of resistance to immunotherapy via LAG-3/FCRL6 engagement
December 12, 2018 / Science
MEK inhibition enhances oncolytic virus immunotherapy through increased tumor cell killing and T cell activation
December 11, 2018 / Clin. Can. Res.
Tumor microenvironment remodeling by intratumoral oncolytic vaccinia virus enhances the efficacy of immune checkpoint blockade
December 5, 2018 / Oncogene
Cisplatin-induced immune modulation in ovarian cancer mouse models with distinct inflammation profiles
December 1, 2018 / Cancer Res.
An Oncolytic Virus Expressing a T-cell Engager Simultaneously Targets Cancer and Immunosuppressive Stromal Cells
December 1, 2018 / Can. Immunol. Res.
Entinostat Converts Immune-Resistant Breast and Pancreatic Cancers into Checkpoint-Responsive Tumors by Reprogramming Tumor-Infiltrating MDSCs
November 27, 2018 / Oncoimmunology.